AUTO1 Group SE (ETR:AG1) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. Overall the results were a little better than the analysts were expecting, with revenues beating forecasts by 2.6%to hit €2.4b. Earnings are an important time for investors, as they can track a company’s performance, look at what the analysts are forecasting for next year, and see if there’s been a change in sentiment towards the company. With this in mind, we’ve gathered the latest statutory forecasts to see what the analysts are expecting for next year.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
Following the latest results, AUTO1 Group’s twelve analysts are now forecasting revenues of €9.92b in 2026. This would be a meaningful 8.7% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 61% to €0.60. Before this earnings report, the analysts had been forecasting revenues of €9.93b and earnings per share (EPS) of €0.60 in 2026. The consensus analysts don’t seem to have seen anything in these results that would have changed their view on the business, given there’s been no major change to their estimates.
View our latest analysis for AUTO1 Group
The analysts reconfirmed their price target of €31.71, showing that the business is executing well and in line with expectations. There’s another way to think about price targets though, and that’s to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on AUTO1 Group, with the most bullish analyst valuing it at €39.00 and the most bearish at €20.45 per share. This shows there is still a bit of diversity in estimates, but analysts don’t appear to be totally split on the stock as though it might be a success or failure situation.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting AUTO1 Group’s growth to accelerate, with the forecast 18% annualised growth to the end of 2026 ranking favourably alongside historical growth of 12% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.3% per year. Factoring in the forecast acceleration in revenue, it’s pretty clear that AUTO1 Group is expected to grow much faster than its industry.
The Bottom Line
The most obvious conclusion is that there’s been no major change in the business’ prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it’s tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn’t be too quick to come to a conclusion on AUTO1 Group. Long-term earnings power is much more important than next year’s profits. We have forecasts for AUTO1 Group going out to 2028, and you can see them free on our platform here.
Don’t forget that there may still be risks. For instance, we’ve identified 1 warning sign for AUTO1 Group that you should be aware of.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content?Get in touchwith us directly.Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
You can copy Bill Ackman and buy Netflix. Knowing why you did is the hard part.
Netflix case is interesting. The scariest competitor is the one that does not need to make money. Amazon can run video at a loss forever because it is really a Prime retention tool with a content budget attached. On the other hand there is Youtube.
Pershing Square hasn’t beaten the S&P over the last five years, though the long-run record is genuinely good. I like Ackman as a person. I enjoy listening to Ackman and that’s about where it ends for me.
Mitchell Lawler
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picks
Fresh 13F filings are where some investors go to find their next stock pick. The problem is it’s missing some of the most important details for making a good investment.
10
Sep 4, 2026
About XTRA:AG1
AUTO1 Group
A technology company, operates a digital automotive platform for buying and selling used cars online in Germany, France, Spain, Italy, and internationally.
High growth potential with acceptable track record.
Similar Companies
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·18 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.9% undervalued
65followersusers have followed this narrative
·1commentusers have commented on this narrative
·17likesusers have liked this narrative
AN
andrei9868on ServiceNow·21 days ago
The Platform Turning Enterprise Chaos into Autonomous Workflows
John_Ericon Vistra·5 days ago
Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here’s the $472 Million Reason They Disagree.
HarishPKon EverQuote·15 days ago
EverQuote and an Asymmetric Investment Opportunity
RecentlyUpdated Narratives
TimLeeon Gold Li Holdings Berhad·about 3 hours ago
Gold Li IPO: Johor Property Developer Builds Its Next Growth Chapter
Fair Value:RM 0.2363.0% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
QU
QuanDon Shopify·about 8 hours ago
The Default Platform for Entrepreneurs that Keeps Compounding
John_Ericon Hamilton Lane·about 12 hours ago
Analysts Cut Their Targets. The Co-Chairman Cut a Check.
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
John_Ericon MercadoLibre·about 15 hours ago
MercadoLibre and the Spreadsheet Trick That Decides Everything
CubanEroson Microsoft·2 months ago
A wonderful business at reasonable price.
Fair Value:US$419.9119.0% overvalued
224followersusers have followed this narrative
·0commentsusers have commented on this narrative
·9likesusers have liked this narrative
